UNSPSC 51311608: Mepyramine tannate

This classification denotes a histamine-1 receptor antagonist with the molecular formula C76H52O46.C17H23N3O, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier A9310LW34B. European Medicines Agency schedules mepyramine tannate in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB03164MIG. Most nations, for tariff and trade purposes, schedule mepyramine tannate under HS 29333999. SMILES:.

UNSPSC 51311608 Mepyramine tannate is a Commodity code that in recent state and local procurement activity describes pharmaceutical supply sourcing, including antihistamines, naloxone, and over-the-counter products distributed through government health and human services channels. State and local governments buying under this code procure finished pharmaceuticals and related health-system supplies for public health initiatives, emergency response programs, and employee health plans. The issuing bodies include state health agencies (such as the Texas Health and Human Services Commission), county public health departments (such as Seminole County, Florida), and state purchasing cooperatives administering multi-jurisdictional pharmaceutical contracts on behalf of member agencies and local governments across multiple states.

Recent activity reflects geographic spread across Texas, Florida, Minnesota, and Oregon, with activity driven primarily by state-level cooperative purchasing vehicles and county health departments. The Minnesota Multistate Cooperative Purchasing Alliance (MMCAP), administered through the Minnesota Department of Administration's Office of State Procurement, posted an RFP on January 20, 2026 (due March 26, 2026) for generic multi-source pharmaceuticals and OTC products distributed to participating state and local government facilities across multiple states, with awarded vendors required to supply through three authorized wholesalers and compliance weighted heavily on price competitiveness (75 percent) and cGMP/Drug Supply Chain Security Act certification. Seminole County, Florida issued IFB 60459723LAS (posted June 30, 2026, due July 26, 2023) to procure 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly deliveries, potentially funded through FEMA. The Texas Health and Human Services Commission issued RFI HHS0017013 (posted April 3, 2026) to gather vendor capabilities for a Therapeutic Pharmacy Initiative Direct-to-Manufacturer Prescriptions program, signaling upstream state interest in alternative pharmaceutical distribution models.